Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

Floating Rate Funds In A COVID-19 World: Buy Or Sell?

researchsnappy by researchsnappy
May 23, 2020
in Advertising Research
0
Floating Rate Funds In A COVID-19 World: Buy Or Sell?
400
SHARES
2.4k
VIEWS
Share on FacebookShare on Twitter

I Need Some Support

Getty

Volatility has taken over, and if you’re like most folks, you’re wondering where to find the safe dividends you need to sustain your savings—and income stream—as this pandemic drags on.

There’s one intriguing alternative you may not have thought of: senior loans, also called floating-rate loans. Because they’re far up the corporate food chain, they offer a layer of safety in the event of bankruptcy, something that’s on every investor’s mind these days.

In addition, senior loans offer yields of 6%, on average, making them an income investor’s dream, too. But are these loans—which I only recommend holding through a closed-end fund (CEF)—a buy today?

Let’s answer that now.

How Senior Loans Protect Your Investment

How safe are senior loans? Think of it this way: when a company liquidates, there’s a long line of people who will be paid out for their investment and a structure saying who gets paid first.

FIIG Securities

FIIG Securities

With this structure, senior loan holders are made whole before owners of a company’s corporate bonds (“subordinated debt” above), convertible bonds and preferred stocks (“hybrids”), and common shares (“equity”). That’s why, for instance, when American Airlines went bankrupt in 2011 and became the new American Airlines (AAL), owners of the old AA stock got basically nothing while many of the company’s lenders lost little or no money.

That’s how it works on paper, anyway; the reality is a bit more complicated.

The Fed Blurs the Picture

Now let’s talk performance and compare the index funds covering investment-grade corporate bonds and floating-rate loans. For corporates, that would be the iShares Investment Grade Corporate Bond ETF (LQD); for floating rates, we’ll use the iShares Floating Rate Bond ETF (FLOT). We see that both are down about the same amount year to date, but they’re down much less than stocks.

These movements make sense. FLOT is less volatile than the bond fund, since it’s less likely to suffer markdowns from defaults, and both ETFs are doing much better than common stocks because stocks have a higher risk of going to zero as bankruptcies rise.

That’s why both LQD and FLOT were decent hedges before the crisis—and they remain good ones if you think COVID-19 will result in widespread bankruptcies at very large corporations. There’s only one problem: the Federal Reserve has made it clear that it will not let that happen. And one of the biggest clichés on Wall Street is a clear command: don’t fight the Fed!

Why not? Because going against Fed policy results in inferior returns over the long haul, and betting that the Fed will let bankruptcies spike over the next year will result in meager returns.

The last time there was a clear-cut situation where the Fed was basically telling you not to buy senior loans was in 2013, when the central bank pumped over a trillion dollars into the economy through its quantitative easing program (which was much smaller than the over $2 trillion the Fed and Treasury are pumping into the US economy right now). Back then, fighting the Fed with FLOT yielded a return of basically zero!

Sure, you didn’t lose money, but you also missed out on the massive gains you could have bagged by rolling with the Fed’s line and buying into the economy through stocks. This year seems to be panning out quite similarly, but with an important twist.

A Better Alternative

The world today is nothing like it was in 2013; with a global pandemic, simply betting on all stocks going up while many companies are being forced to shut down will result in a portfolio with a lot of losers mixed in with the winners. It’s one reason why, throughout this pandemic, I’ve been banging the drum for a return to value investing—and the funds that know which value-investing tools to employ.

That’s a big reason why in mid-March, I suggested looking at the Boulder Growth & Income Fund (BIF), which invests in Warren Buffett’s Berkshire Hathaway

BRK.B
(BRK.A)
and other Buffett-approved stocks, like JP Morgan Chase & Co. (JPM

JPM
)
and American Express

AXP
(AXP).

Value Investing Pays Off in a Crisis

This value-investing fund shot up 10% in no time. Today, with a 17% discount to NAV and a 4.4% yield, BIF hasn’t attracted nearly as many buyers as it likely will when investors realize they can buy a fund that carefully chooses which stocks to buy and which to avoid—without the humdrum low returns of a floating-rate fund. That makes a huge difference over the long haul.

And you can get set for BIF’s next upward move now, without being invested in the overvalued companies most likely to go bust due to the pandemic.

Michael Foster is the Lead Research Analyst for Contrarian Outlook. For more great income ideas, click here for our latest report “Indestructible Income: 5 Bargain Funds with Safe 11% Dividends.”

Disclosure: none

Previous Post

MRSI elects Sandeep Arora as President 

Next Post

Wharton Neuroscience Initiative receives $10 million donation for research, equipment

Next Post
Wharton Neuroscience Initiative receives $10 million donation for research, equipment

Wharton Neuroscience Initiative receives $10 million donation for research, equipment

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News
  • Top Company News

HPIN International Financial Platform Becomes a New Benchmark for India’s Digital Economy

Top 10 Market Research Companies in the world

3 Best Market Research Certifications in High Demand

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2025 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2025 researchsnappy.com